Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · May 15, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how hepatitis B markers change in people who are living with HIV and receiving injectable treatments. The goal is to understand the risk of hepatitis B getting worse (reactivation) in these patients. Researchers want to learn more about how these markers behave over time to help improve care for individuals with both HIV and hepatitis B.

To participate in this trial, you need to be an adult aged 65 to 74 who is living with HIV and currently receiving injectable antiretroviral therapy (ART). However, if you have an active hepatitis B infection, you won’t be eligible to join. Since the study is not yet recruiting participants, there's still time to learn more about it. If you do join, you can expect to provide information about your health and undergo some tests to monitor your hepatitis B markers. This research could help doctors understand how to better manage your health if you have both HIV and hepatitis B.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -HIV infected patients under injectable ART
• Exclusion Criteria:
• • -Active HBV infection